Hypertension is a major risk factor for cardiovascular disease morbidity and mortality including myocardial infarction, congestive heart failure, stroke, renal disease and dementia.
Their blood pressure usually remains above 140/90 mmHg despite the appropriate lifestyle measures and the provision of at least 3 anti-Hypertensive drugs.
Res-HTN has been associated with a 1.1-3 fold increase in the risk of cardiovascular events.
Primary aldosteronism (PA) is a type of hormonal disorder that leads to high blood pressure. Currently, PA is detected late (8-12 years after onset of hypertension).
Too few Direct Renin/PRA and Aldosterone tests are prescribed by Specialists to exclude PA, leaving Renovascular Hypertension undiagnosed and untreated.
Test all res-HTN patients with Aldosterone and Direct Renin Assays for a rapid Primary Aldosteronism (PA) diagnosis. ¹ ⁵
Early diagnosis of PA leads to the administration of effective treatments, which can reduce the impact and improve prognosis.
The new combination of LIAISON® Direct Renin and Aldosterone automated assays allows meaningful PA diagnosis with a comparable specificity and sensitivity to existing methods